APA (7th ed.) Citation

Budda, B., Mitra, A., Park, L., Long, H., Kurnellas, M., Bien-Ly, N., . . . Rosenthal, A. (2025). Development of AL101 (GSK4527226), a progranulin-elevating monoclonal antibody, as a potential treatment for Alzheimer's disease. Alzheimer's Research & Therapy, 17(1), 1. https://doi.org/10.1186/s13195-025-01817-4

Chicago Style (17th ed.) Citation

Budda, Balasubrahmanyam, et al. "Development of AL101 (GSK4527226), a Progranulin-elevating Monoclonal Antibody, as a Potential Treatment for Alzheimer's Disease." Alzheimer's Research & Therapy 17, no. 1 (2025): 1. https://doi.org/10.1186/s13195-025-01817-4.

MLA (9th ed.) Citation

Budda, Balasubrahmanyam, et al. "Development of AL101 (GSK4527226), a Progranulin-elevating Monoclonal Antibody, as a Potential Treatment for Alzheimer's Disease." Alzheimer's Research & Therapy, vol. 17, no. 1, 2025, p. 1, https://doi.org/10.1186/s13195-025-01817-4.